Requesting conflicts of interest declarations from the European Medicines Agency: 3-year follow-up status
Abstract Aims We have previously described the European Medicines Agency's (EMA) and the US Food and Drug Administration's guidelines, each for a specific psychiatric indication, on how to design pivotal drug trials used in new drug applications. Here, we report on our efforts over 3 years...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Cambridge University Press,
2024-01-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|